Norethindrone, 2 Mg.: An Evaluation
Behrman, S.J.
Obstetrics and Gynecology 24: 101-105
1964
ISSN/ISBN: 0029-7844 PMID: 14211016 Document Number: 479537
Document emailed within 1 workday
Related Documents
Laumas, V.; Malik, B.K.; Jamal, K.; Seth, U.; Agarwal, N.; Hingorani, V.; Laumas, K.R. 1978: Radioimmunoassay of norethindrone : serum levels of norethindrone in lactating women after insertion of a single Silastic implant releasing norethindrone acetate Contraception 18(6): 593-605Odlind, V.; Weiner, E.; Victor, A.; Johansson, E.D. 1979: Plasma levels of norethindrone after single oral dose administration of norethindrone and lynestrenol Clinical Endocrinology 10(1): 29-38
Odlind, V.; Weiner, E.; Johansson, E.D. 1979: Plasma levels of norethindrone and effect upon ovarian function during treatment with silastic implants containing norethindrone Contraception 19(2): 197-206
Shahani, S.M.; Kulkarni, P.P. 1982: Clinical evaluation of interval contraception by norethindrone acetate implant Indian Journal of Medical Research 76: 561-564
Grubb, G.S.; Welch, J.D.; Cole, L.; Goldsmith, A.; Rivera, R. 1989: A comparative evaluation of the safety and contraceptive effectiveness of 65 mg and 100 mg of 90-day norethindrone (NET) injectable microspheres: a multicenter study Fertility and Sterility 51(5): 803-810
De Sampaio Júnior, L.F.; Dib, J.E.; Pereira, V.M.; Neme, B. 1971: Evaluation of the efficacy and side effects of the contraceptive containing 0.5 mg of norethindrone and 0.1 mg of mestranol in a family planning clinic Maternidade e Infancia; Arquivos Medicos-Sociais 30(1): 65-69
Grubb, G.S.; Welch, J.D.; Cole, L.; Goldsmith, A.; Rivera, R. 1989: A comparative evaluation of the safety and contraceptive effectiveness of 65 mg and 100 mg of 90-day norethindrone (NET) injectable microspheres: a multicenter study Fertility and Sterility 51(5): 803-810
Ahmad, M.E.; Shadab, G.G.; Azfer, M.A.; Afzal, M. 2001: Evaluation of genotoxic potential of synthetic progestins-norethindrone and norgestrel in human lymphocytes in vitro Mutation Research 494(1-2): 13-20
Takkar, D.; Anandalaxmi, P.N.; Chandra, V.L.; Bhatnagar, S.; Yadav, H.S.; Laumas, K.R.; Hingorani, V.; Krishna, U.; Mandleker, A.; Purandare, V.N.; Goel, V.; Adatia, A.; Virker, K.D. 1978: Long-term contraception by a single silastic implant-D containing norethindrone acetate in women: a clinical evaluation Contraception 17(4): 341-354
Goldzieher, J.W.; Moses, L.E.; Ellis, L.T. 1962: Study of norethindrone in contraception JAMA 180(5): 359-361
Francis, W.G. 1964: 2 Mg. Norethindrone-Mestranol in Contraception and Therapy Applied Therapeutics 6: 419-423
Taitel, H.F.; Kafrissen, M.E. 1995: Norethindrone--a review of therapeutic applications International Journal of Fertility and Menopausal Studies 40(4): 207-223
Santos, M.; Hendry, D.; Sangi-Haghpeykar, H.; Dietrich, J.E. 2014: Retrospective review of norethindrone use in adolescents Journal of Pediatric and Adolescent Gynecology 27(1): 41-44
Neme, B.; von Atzingen, I.J.; Salomão, A.J.; Santos, E.P.; Behle, I. 1971: 0.35 mg of norethindrone in the control of human fertility Maternidade E Infancia; Arquivos Medicos-Sociais 30(3): 297-315
Moghissi, K.S.; Syner, F.N.; McBride, L.C. 1973: Contraceptive mechanism of microdose norethindrone Obstetrics and Gynecology 41(4): 585-594
Prasad, K.V.; Rao, B.S.; Sivakumar, B.; Prema, K. 1979: Pharmacokinetics of norethindrone in Indian Women Contraception 20(1): 77-90
Dickinson, J.H.; Smith, G.G. 1963: A new and practical oral contraceptive agent: norethindrone with mestranol Canadian Medical Association Journal 89: 242-245
Rice-wray, E.; Schulz-contreras, M.; Guerrero, I.; Aranda-rosell, A. 1962: Long-term administration of norethindrone in fertility control JAMA 180(5): 355-358
Wiese, J.; Marker, I.L.; Holma, P.; Vartiainen, E.; Osler, M.; Pyörälä, T.; Johansson, E.; Luukkainen, T. 1976: Long-term contraception with norethindrone subcutaneous capsules Annals of Clinical Research 8(2): 93-97
Beer, M.A. 1964: Contraceptive Efficacy of Norethindrone with Mestranol: new low Dosage Form Journal of the Medical Society of New Jersey 61: 449-453